Sensus Healthcare (NASDAQ:SRTS) Director Eric Sachetta Acquires 34,697 Shares of Stock

Sensus Healthcare, Inc. (NASDAQ:SRTS) Director Eric Sachetta acquired 34,697 shares of Sensus Healthcare stock in a transaction on Monday, August 24th. The shares were bought at an average cost of $3.25 per share, with a total value of $112,765.25. Following the completion of the purchase, the director owned 209,310 shares in the company, valued at $680,257.50. The trade was a 19.87% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.

Sensus Healthcare Stock Performance

Sensus Healthcare stock opened at $3.36 on Wednesday. The stock’s fifty day moving average is $3.01 and its two-hundred day moving average is $3.55. The firm has a market capitalization of $55.31 million, a price-to-earnings ratio of -3.57 and a beta of 1.10. Sensus Healthcare, Inc. has a fifty-two week low of $2.66 and a fifty-two week high of $5.49.

Sensus Healthcare (NASDAQ:SRTS) last released its quarterly earnings results on Thursday, August 13th. The company reported ($0.53) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.41). Sensus Healthcare had a negative return on equity of 21.57% and a negative net margin of 88.45%.The firm had revenue of $2.29 million for the quarter, compared to analyst estimates of $4.60 million.

Analyst Ratings Changes

SRTS has been the subject of a number of research analyst reports. Alliance Global Partners restated a “buy” rating on shares of Sensus Healthcare in a report on Monday, August 17th. Weiss Ratings cut Sensus Healthcare from a “sell (d)” rating to a “sell (d-)” rating in a report on Tuesday, August 18th. Citigroup restated a “buy” rating on shares of Sensus Healthcare in a research note on Friday, May 8th. Wall Street Zen downgraded Sensus Healthcare from a “sell” rating to a “strong sell” rating in a report on Saturday, May 9th. Finally, Lake Street Capital reduced their price objective on Sensus Healthcare from $4.50 to $4.00 and set a “buy” rating on the stock in a research note on Friday, August 14th. Four analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $5.83.

Institutional Trading of Sensus Healthcare

Several large investors have recently added to or reduced their stakes in the stock. EP Wealth Advisors LLC acquired a new position in shares of Sensus Healthcare during the second quarter worth about $49,000. XTX Topco Ltd acquired a new stake in shares of Sensus Healthcare in the fourth quarter valued at about $77,000. Jane Street Group LLC purchased a new stake in shares of Sensus Healthcare during the 4th quarter valued at about $79,000. Ingalls & Snyder LLC purchased a new stake in shares of Sensus Healthcare during the 4th quarter valued at about $219,000. Finally, BlackRock Inc. acquired a new position in Sensus Healthcare during the 2nd quarter worth approximately $252,000. 25.30% of the stock is currently owned by institutional investors and hedge funds.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc is a medical technology company specializing in the development, manufacture and commercialization of superficial radiation therapy (SRT) systems. The company’s SRT devices utilize low-energy X-rays to treat a range of dermatological and oncological conditions, most notably non-melanoma skin cancers such as basal cell carcinoma and squamous cell carcinoma, as well as benign lesions including keloids. By delivering targeted radiation to superficial tissue layers, Sensus Healthcare’s systems aim to provide an alternative to surgical excision or systemic therapies, offering clinicians a non-invasive treatment option for eligible patients.

The company’s flagship products include the SRT-100™ and SRT-100+™ platforms, which feature handheld applicators, adjustable energy settings and integrated safety controls.